dexefaroxan has been researched along with Brain Ischemia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chopin, P; Colpaert, FC; Debeir, T; Marien, MR; Raisman-Vozari, R | 1 |
| Colpaert, F; Debeir, T; Ferrario, J; Marien, M; Prigent, A; Raisman-Vozari, R; Rizk, P | 1 |
2 other study(ies) available for dexefaroxan and Brain Ischemia
| Article | Year |
|---|---|
Protective effect of the alpha2-adrenoceptor antagonist, dexefaroxan, against spatial memory deficit induced by cortical devascularization in the adult rat.
Topics: Adrenergic alpha-2 Receptor Antagonists; Adrenergic alpha-Antagonists; Animals; Behavior, Animal; Benzopyrans; Brain Ischemia; Cerebral Cortex; Imidazoles; Male; Memory Disorders; Rats; Rats, Sprague-Dawley; Spatial Behavior; Vascular Surgical Procedures | 2004 |
In vivo upregulation of endogenous NGF in the rat brain by the alpha2-adrenoreceptor antagonist dexefaroxan: potential role in the protection of the basalocortical cholinergic system during neurodegeneration.
Topics: Acetylcholine; Adrenergic alpha-2 Receptor Antagonists; Animals; Benzopyrans; Brain Ischemia; Enzyme-Linked Immunosorbent Assay; Imidazoles; Immunohistochemistry; Nerve Degeneration; Nerve Growth Factor; Neurons; Neuroprotective Agents; Rats; Somatosensory Cortex; Up-Regulation | 2004 |